Por: The Boston Globe Business April 26, 2023
Cambridge scientists are deploying a novel gene-silencing technology used against ultra-rare diseases in a new effort to subdue Alzheimer’s, the memory-raving disorder that afflicts tens of millions of people worldwide.In findings reported Wednesday afternoon, Alnylam Pharmaceuticals said a small number of patients in an early-stage clinical study showed reductions of 84 to 90 percent in the levels of protein seen in the cerebrospinal fluid... + full article
The Boston Globe USA Business April 26, 2023
Orbital Therapeutics, a new Cambridge-based startup that boasts some of the most familiar names in biotechnology, said Wednesday that it has raised $270 million in the company’s first fund-raising round, despite the deep slump in the business sector.Orbital plans to use the... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
Forbes USA Tech March 11, 2023
Genetic engineeering concept with 3d rendering dna helix and a part of dnagetty This article is the eighth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , , , , , and of the series. If you are a person who has inherited the APOE4... + más
A Promising Trial Targets a Genetic Risk for Alzheimer’s | The New York Times
Chris Hemsworth discovers he may be at risk for Alzheimer’s disease in new series, ‘Limitless’ | ABC News
The Advocate USA Health January 02, 2023
What is Alzheimer’s disease?German neurologist Dr. Alois Alzheimer first identified this neurological disorder in 1906 while studying the pathology of a woman he had treated for an unusual mental illness.While examining her brain after her death, Alzheimer noticed marked... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
The Boston Globe USA Business October 27, 2022
Alnylam Pharmaceuticals Inc. said it’s stopping work on a treatment for a rare eye disease because of a new US drug-pricing law with the potential to limit how much it could charge for the medication in the future.Alnylam will not begin a planned late-stage trial of its drug... + más
ALNY Reiterates Guidance, TVTX Loss Widens, DXCM Paints Rosy Outlook | RTTNews
Halted Stocks | Forbes
Forbes USA Tech October 22, 2022
A person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
Variety of factors play a role in the development of Alzheimer's | The Advocate
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Portland Press Herald USA Health September 24, 2022
A study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más
About iurex | Privacy Policy | Disclaimer |